SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 69 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $161,000 | -22.2% | 36,093 | -5.0% | 0.07% | -16.5% |
| Q2 2021 | $207,000 | +7.3% | 37,977 | +47.4% | 0.08% | +3.7% |
| Q1 2021 | $193,000 | -29.8% | 25,773 | +1.8% | 0.08% | -28.1% |
| Q4 2020 | $275,000 | -10.7% | 25,323 | -27.3% | 0.11% | -29.6% |
| Q3 2020 | $308,000 | -27.0% | 34,835 | -12.0% | 0.16% | -19.0% |
| Q2 2020 | $422,000 | -0.5% | 39,578 | +11.2% | 0.20% | +354.5% |
| Q3 2018 | $424,000 | -32.7% | 35,601 | -42.3% | 0.04% | -92.1% |
| Q2 2018 | $630,000 | – | 61,719 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 4,806,656 | $58,449,000 | 19.02% |
| Casdin Capital, LLC | 182,141 | $2,215,000 | 1.83% |
| Aisling Capital LLC | 508,565 | $6,184,000 | 1.44% |
| Redmile Group, LLC | 948,440 | $11,533,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,812,778 | $22,043,000 | 0.91% |
| EcoR1 Capital, LLC | 63,596 | $773,000 | 0.25% |
| Eventide Asset Management | 150,000 | $1,824,000 | 0.12% |
| AWM Investment Company, Inc. | 47,550 | $578,000 | 0.11% |
| Weiss Multi-Strategy Advisers LLC | 49,000 | $596,000 | 0.03% |
| Baker Brothers Advisors | 204,465 | $2,486,000 | 0.02% |